Gary Frazier, Chief Growth Officer at Helio Genomics
What You Should Know:
– Helio Genomics, an AI-driven healthcare company specializing in diagnostics technology for cancer detection, has appointed Gary Frazier as its Chief Growth Officer.
– Frazier’s…
Continue Reading
The SNMMI Mid-Winter Conference in Orlando, Florida, from February 1st to 3rd, 2024, convened over 700 experts in nuclear medicine and molecular imaging. Through educational tracks, sessions, and symposia, attendees explored the latest advancements…
Continue Reading
RaySearch Laboratories celebrates a pivotal milestone as RayStation, their cutting-edge treatment planning system, gains traction in over 1,000 radiotherapy centers worldwide. With a stronghold in the United States, Japan, and China, RayStation’s versatility supports…
Continue Reading
While most would agree that everyone should have the same opportunity to prevent, detect, treat and survive cancer, unfortunately for many, this is not the case. Billions of dollars are being invested into cancer…
Continue Reading
Local infusion centers are jumping in to fulfill doctors’ infusion orders when their hospitals – such as Sacred Heart and St. Joseph’s in Eau Claire, Wisconsin – prepare to close, which Hospital Sisters Health System said last…
Continue Reading
Welcome to the January edition of Digital Health Digest on our YouTube channel! Dive into the latest and most exciting advancements in digital healthcare, from cutting-edge diagnostic tools to innovative telehealth services. In this…
Continue Reading
Riverrain’s ClearRead CT technology, chosen by the U.S. Department of Veterans Affairs, is transforming lung cancer diagnostics for nearly 8,000 veterans annually. The software’s AI-powered precision measurements promise consistency, alleviating radiology burnout and talent…
Continue Reading
What You Should Know:
– ArteraAI, a pioneer in multi-modal artificial intelligence (MMAI) for cancer treatment personalization, announced today an additional $20M in funding.
– This latest round, backed by prominent investors like Prosperity7 Ventures, EDBI,…
Continue Reading
Background: Androgen deprivation therapy (ADT), a standard treatment for prostate cancer (PC), causes many physical side effects. In particular, it causes metabolic changes such as fasting glucose abnormalities or accumulation of body fat, and…
Continue Reading
NHS Cheshire and Merseyside’s Radiology Imaging Network (CAMRIN) has secured funding from the NHS Transformation Directorate’s AI Diagnostic Fund to accelerate the deployment of AI to help diagnose lung cancer patients quicker.Up to £1.2…
Continue Reading
